JP2011513374A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513374A5 JP2011513374A5 JP2010549188A JP2010549188A JP2011513374A5 JP 2011513374 A5 JP2011513374 A5 JP 2011513374A5 JP 2010549188 A JP2010549188 A JP 2010549188A JP 2010549188 A JP2010549188 A JP 2010549188A JP 2011513374 A5 JP2011513374 A5 JP 2011513374A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- yloxy
- carboxylic acid
- azetidine
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0804006.5A GB0804006D0 (en) | 2008-03-04 | 2008-03-04 | Azetidine derivatives |
| GB0804006.5 | 2008-04-05 | ||
| GBGB0821694.7A GB0821694D0 (en) | 2008-11-27 | 2008-11-27 | Azetidine derivatives |
| GB0821694.7 | 2008-11-27 | ||
| PCT/GB2009/000568 WO2009109743A1 (en) | 2008-03-04 | 2009-02-27 | Azetidine derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014198461A Division JP5986163B2 (ja) | 2008-03-04 | 2014-09-29 | アゼチジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011513374A JP2011513374A (ja) | 2011-04-28 |
| JP2011513374A5 true JP2011513374A5 (enExample) | 2012-03-29 |
| JP5624894B2 JP5624894B2 (ja) | 2014-11-12 |
Family
ID=40613126
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010549188A Active JP5624894B2 (ja) | 2008-03-04 | 2009-02-27 | アゼチジン誘導体 |
| JP2014198461A Active JP5986163B2 (ja) | 2008-03-04 | 2014-09-29 | アゼチジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014198461A Active JP5986163B2 (ja) | 2008-03-04 | 2014-09-29 | アゼチジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US8450346B2 (enExample) |
| EP (1) | EP2265578B1 (enExample) |
| JP (2) | JP5624894B2 (enExample) |
| CN (1) | CN102015635B (enExample) |
| AU (1) | AU2009220974B2 (enExample) |
| BR (1) | BRPI0909782B8 (enExample) |
| CA (1) | CA2717750C (enExample) |
| DK (1) | DK2265578T3 (enExample) |
| EA (1) | EA017842B1 (enExample) |
| ES (1) | ES2550367T3 (enExample) |
| HU (1) | HUE025411T2 (enExample) |
| IL (1) | IL207768A (enExample) |
| MX (1) | MX2010009658A (enExample) |
| NZ (1) | NZ587532A (enExample) |
| PL (1) | PL2265578T3 (enExample) |
| PT (1) | PT2265578E (enExample) |
| WO (1) | WO2009109743A1 (enExample) |
| ZA (1) | ZA201006270B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102015635B (zh) | 2008-03-04 | 2013-05-08 | 弗奈利斯（R&D）有限公司 | 氮杂环丁烷衍生物 |
| US20130150346A1 (en) | 2010-01-08 | 2013-06-13 | Quest Ventures Ltd. | Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
| WO2011123719A2 (en) | 2010-03-31 | 2011-10-06 | Ironwood Pharmaceuticals, Inc. | Use of faah inhibitors for treating abdominal, visceral and pelvic pain |
| KR101273566B1 (ko) | 2011-09-05 | 2013-06-11 | 한국과학기술연구원 | 신규한 아제티딘 유도체 및 이를 함유하는 항우울제 조성물 |
| JP6232384B2 (ja) * | 2012-01-06 | 2017-11-15 | ノバルティス アーゲー | 複素環式化合物およびその使用方法 |
| US10570146B2 (en) * | 2014-07-25 | 2020-02-25 | Northeastern University | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof |
| JOP20190072A1 (ar) * | 2016-10-13 | 2019-04-07 | Glaxosmithkline Ip Dev Ltd | مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم |
| JP7282028B2 (ja) * | 2017-06-02 | 2023-05-26 | 富士フイルム富山化学株式会社 | 脳萎縮予防または治療剤 |
| RU2728717C1 (ru) * | 2017-06-02 | 2020-07-30 | ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. | Средство для профилактики или лечения спиноцеребеллярной атаксии |
| US11541033B2 (en) | 2017-06-02 | 2023-01-03 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating Alzheimer's disease |
| CN110691594A (zh) * | 2017-06-02 | 2020-01-14 | 富士胶片富山化学株式会社 | Tau蛋白病预防或治疗剂 |
| KR20200003102A (ko) | 2017-06-02 | 2020-01-08 | 후지필름 도야마 케미컬 가부시키가이샤 | 아밀로이드 β 단백질량 감소제 |
| JP7227914B2 (ja) | 2017-10-30 | 2023-02-22 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
| US20240180905A1 (en) * | 2020-07-21 | 2024-06-06 | Neuritek Ltd. | Uses of fatty acid amide hydrolase inhibitors in treatment of trauma related psychiatric disorders |
| CN112374984A (zh) * | 2020-11-06 | 2021-02-19 | 苏州求索生物科技有限公司 | 一种2-溴-4-羟基苯甲醚的制备工艺 |
| US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
| US11795146B2 (en) | 2021-10-11 | 2023-10-24 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (CB1) modulator and methods of use and preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5183902A (en) | 1985-02-28 | 1993-02-02 | A. H. Robins Company, Incorporated | Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides |
| IN162808B (enExample) * | 1985-02-28 | 1988-07-09 | Robins Co Inc A H | |
| US6335445B1 (en) * | 1997-03-24 | 2002-01-01 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| GB9801501D0 (en) * | 1998-01-23 | 1998-03-18 | Cerebrus Ltd | Chemical compounds - II |
| FR2866884B1 (fr) * | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
| CN102015635B (zh) * | 2008-03-04 | 2013-05-08 | 弗奈利斯（R&D）有限公司 | 氮杂环丁烷衍生物 |
-
2009
- 2009-02-27 CN CN2009801079287A patent/CN102015635B/zh active Active
- 2009-02-27 EA EA201001414A patent/EA017842B1/ru not_active IP Right Cessation
- 2009-02-27 PT PT97167126T patent/PT2265578E/pt unknown
- 2009-02-27 HU HUE09716712A patent/HUE025411T2/en unknown
- 2009-02-27 NZ NZ587532A patent/NZ587532A/en unknown
- 2009-02-27 ES ES09716712.6T patent/ES2550367T3/es active Active
- 2009-02-27 JP JP2010549188A patent/JP5624894B2/ja active Active
- 2009-02-27 CA CA2717750A patent/CA2717750C/en active Active
- 2009-02-27 WO PCT/GB2009/000568 patent/WO2009109743A1/en not_active Ceased
- 2009-02-27 EP EP09716712.6A patent/EP2265578B1/en active Active
- 2009-02-27 US US12/920,181 patent/US8450346B2/en active Active
- 2009-02-27 BR BRPI0909782A patent/BRPI0909782B8/pt active IP Right Grant
- 2009-02-27 PL PL09716712T patent/PL2265578T3/pl unknown
- 2009-02-27 AU AU2009220974A patent/AU2009220974B2/en active Active
- 2009-02-27 DK DK09716712.6T patent/DK2265578T3/en active
- 2009-02-27 MX MX2010009658A patent/MX2010009658A/es active IP Right Grant
-
2010
- 2010-08-24 IL IL207768A patent/IL207768A/en active IP Right Grant
- 2010-09-01 ZA ZA2010/06270A patent/ZA201006270B/en unknown
-
2013
- 2013-04-19 US US13/866,059 patent/US9006269B2/en active Active
-
2014
- 2014-09-29 JP JP2014198461A patent/JP5986163B2/ja active Active
-
2015
- 2015-03-09 US US14/641,783 patent/US9475800B2/en active Active
-
2016
- 2016-09-28 US US15/278,386 patent/US10383871B2/en active Active
-
2019
- 2019-07-09 US US16/506,225 patent/US10918640B2/en active Active
-
2021
- 2021-01-14 US US17/148,785 patent/US12246014B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009510043A5 (enExample) | ||
| CN104334529B (zh) | 用于抑制abl1、abl2和bcr‑abl1的活性的化合物和组合物 | |
| JP5985611B2 (ja) | 炎症および免疫関連用途のための化合物 | |
| JP2010508288A5 (enExample) | ||
| JP2011502982A5 (enExample) | ||
| JP2013542937A5 (enExample) | ||
| US20090186891A1 (en) | Organic compounds | |
| JP2017524005A5 (enExample) | ||
| JP2007529484A5 (enExample) | ||
| JP2010513438A5 (enExample) | ||
| JP2009533410A5 (enExample) | ||
| JP2012526107A5 (enExample) | ||
| JP2008513515A5 (enExample) | ||
| JP2010505809A5 (enExample) | ||
| JP2011519854A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| ME02047B (me) | Nova jedinjenja koja se vezuju za fxr (nr1 h4) i moduliraju njegovu aktivnost | |
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| JP2011529049A5 (enExample) | ||
| JP2013529210A5 (enExample) | ||
| JP2010502615A (ja) | ５−リポキシゲナーゼ活性化タンパク質（ｆｌａｐ）の阻害剤 | |
| JP2013535424A5 (enExample) | ||
| JP2010513397A5 (enExample) | ||
| JP2011510055A5 (enExample) | ||
| JP2013539747A5 (enExample) |